posted stronger-than-expected third quarter earnings Wednesday, powered by gains in its pharmacy and health care benefits division, but stuck to its full-year profit forecasts.
Pharmacy & Consumer sales, which were formerly reported in the Retail segment, were up 6% to $28.87 billion,"driven increased prescription volume and brand inflation,' CVS said. Health Care Benefits revenues were up 16.9% to $26.3 billion.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
CVS Health’s stock up after earnings beat, but company lowers full-year EPS guidanceCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Fonte: MarketWatch - 🏆 3. / 97 Consulte Mais informação »